{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:02:04Z","timestamp":1793394124864,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roche Pharma"},{"name":"Sanofi-Genzyme"},{"DOI":"10.13039\/100010795","name":"Chugai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jpeds.2018.07.065","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T04:45:02Z","timestamp":1539060302000},"page":"225-233.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-9553","authenticated-orcid":false,"given":"Bertrand","family":"Lioger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ternant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Passot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Paintaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Bejan-Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.07.065_bib0010","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10245332.2016.1219497","article-title":"Advances in the pathophysiology of primary immune thrombocytopenia","volume":"22","author":"Perera","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0020","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","article-title":"Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases","volume":"114","author":"Psaila","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0030","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2005.04.032","article-title":"Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials","volume":"147","author":"Beck","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0045","first-page":"57","article-title":"Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia","volume":"3","author":"Cheung","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.hoc.2009.09.002","article-title":"Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia","volume":"23","author":"Cooper","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/fcp.12198","article-title":"Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study","volume":"30","author":"Eghbali","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s12098-008-0243-y","article-title":"Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura","volume":"75","author":"Shahgholi","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0065","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/pbc.24633","article-title":"Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning","volume":"60","author":"Thompson","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0070","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mpd.2002.128547","article-title":"Grading of hemorrhage in children with idiopathic thrombocytopenic purpura","volume":"141","author":"Buchanan","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1185\/03007995.2011.644849","article-title":"Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia","volume":"28","author":"Fogarty","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpeds.2005.11.019","article-title":"Single dose of anti-D immune globulin at 75 microg\/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children","volume":"148","author":"Tarantino","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000089465","article-title":"Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura","volume":"115","author":"El Alfy","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MPH.0b013e31817541ba","article-title":"A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children","volume":"30","author":"Son","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPH.0b013e31820e2aa5","article-title":"Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia","volume":"33","author":"Papagianni","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MBC.0b013e32835e5337","article-title":"A comparison of intravenous immunoglobulin (2\u2009g\/kg totally) and single doses of anti-D immunoglobulin at 50\u2009\u00b5g\/kg, 75\u2009\u00b5g\/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience","volume":"24","author":"Alioglu","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11239-012-0801-z","article-title":"Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura","volume":"35","author":"Celik","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/pbc.22701","article-title":"Immunoglobulin anti- D for treatment of chronic ITP in children","volume":"55","author":"Iacobini","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0120","first-page":"10","article-title":"Comparison of Intravenous Immunoglobulin (IVIG) and intravenous anti-D for treatment of acute idiopathic thrombocytopenic purpura","author":"Farahmandinia","year":"2010","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MPH.0b013e318142ac5f","article-title":"Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia","volume":"29","author":"Alioglu","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0135","first-page":"35","article-title":"Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature","volume":"78","author":"Schiavotto","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-9-28","article-title":"Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease","volume":"9","author":"Kemmotsu","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1537-2995.2008.01721.x","article-title":"Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis","volume":"48","author":"Daw","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0150","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/trf.14289","article-title":"Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility","volume":"57","author":"Mielke","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2215\/CJN.04540709","article-title":"Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients","volume":"4","author":"Kahwaji","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.22261","article-title":"Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects","volume":"87","author":"Long","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpeds.2018.07.065_bib0165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2004-11-4303","article-title":"Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura","volume":"106","author":"Gaines","year":"2005","journal-title":"Blood"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618309740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618309740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T04:51:51Z","timestamp":1545195111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347618309740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"alternative-id":["S0022347618309740"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.065","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.062","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}